homeWelcome, sign in or click here to subscribe.login
     


 

 

Construction


print  email to a friend  reprints add to mydjc  

September 30, 2003

Skanska

Skanska USA Building has formed Skanska Pharmaceutical Group to provide validation of pharmaceutical and biotech facilities for FDA approval. The new group will operate within Skanska’s Science and Technology Division and will he headed by industry veterans Andrew D. Skibo and Wael Allan. Skibo is president of the new group and executive vice president of the Science and Technology Division. Allan is senior vice president, and is serving as managing director of Skanska Pharmaceutical Group's United Kingdom entity. Skanska has pharmaceutical clients in the Seattle area, as well as other parts of the world. The Pharmaceutical Group will operate from the firm's USA headquarters in Parsippany, N.J.




Email or user name:
Password:
 
Forgot password? Click here.